Avastin use in high risk corneal transplantation

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 12, 2009, Pages 1701-1706

  Vassileva, Petja Ivanova ^a   Hergeldzhieva, Tatyana Georgieva ^a  

^a University Eye Hospital Prof Pashev   (Bulgaria)

Author keywords

Corneal neovascularization; Corneal transplantation; Penetrating keratoplasty; Subconjunctival Avastin

Indexed keywords

BEVACIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHEMICAL BURN; CLINICAL ARTICLE; CORNEA DYSTROPHY; CORNEA NEOVASCULARIZATION; CORNEA TRANSPLANTATION; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; EYE INFECTION; FEMALE; GRAFT FAILURE; HERPES SIMPLEX KERATITIS; HIGH RISK PATIENT; HUMAN; KERATOCONUS; MALE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PSEUDOPHAKIA; TREATMENT INDICATION; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CONJUNCTIVA; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; FEMALE; HUMANS; INJECTIONS; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 71449087265     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1170-y     Document Type: Article

References (10)

1. AJ George DF Larkin 2004 Corneal transplantation: the forgotten graft Am J Transplant 4 5 678 685 10.1111/j.1600-6143.2004.00417.x 1:STN:280: DC%2BD2c7ovVCnug%3D%3D 15084160 (Pubitemid 38659465)
2. J Folkman 1995 Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27 31 10.1038/nm0195-27 1:CAS:528:DyaK2MXjs1KnsLk%3D 7584949
3. W Philipp L Speicher C Humpel 2000 Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas Invest Ophthalmol Vis Sci 41 2514 2522 1:STN:280:DC%2BD3czps1WqtQ%3D%3D 10937562
4. Barraquer J, Rutllan J (1984) Microsurgery of the cornea; an Atlas and Textbook. Ediciones Scriba, Barcelona
5. RP Manzano GA Peyman P Khan PE Carvounis M Kivilcim M Ren JC Lake P Chévez-Barrios 2007 Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin) Br J Ophthalmol 91 6 804 807 10.1136/bjo.2006.107912 17179168 (Pubitemid 46846656)
6. LF Barros R Belfort Jr 2007 The effects of the subconjunctival injection of bevacizumab (Avastin) on angiogenesis in the rat cornea An Acad Bras Cienc 79 3 389 394 1:CAS:528:DC%2BD2sXht1ylurfN 17768531
7. Tübingen Bevacizumab Study Group E Yoeruek F Ziemssen S Henke-Fahle O Tatar A Tura S Grisanti KU Bartz-Schmidt P Szurman 2008 Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn Acta Ophthalmol 86 3 322 328 10.1111/j.1600-0420.2007.01049.x 17995975 (Pubitemid 351785106)
8. I Bahar I Kaiserman P McAllum D Rootman A Slomovic 2008 Subconjunctival bevacizumab injection for corneal neovascularization Cornea 27 2 142 147 10.1097/ICO.0b013e318159019f 18216566 (Pubitemid 351158729)
9. M Erdurmus Y Totan 2007 Subconjunctival bevacizumab for corneal neovascularization Graefes Arch Clin Exp Ophthalmol 245 10 1577 1579 10.1007/s00417-007-0587-4 1:CAS:528:DC%2BD2sXhtVajs73M 17458556 (Pubitemid 47423342)
10. A Awadein 2007 Subconjunctival bevacizumab for vascularized rejected corneal grafts J Cataract Refract Surg 33 11 1991 1993 10.1016/j.jcrs.2007.07. 012 17964413 (Pubitemid 47615364)